|Validation of the BPLab(®) 24-hour blood pressure monitoring system according to the European standard BS EN 1060-4:2004 and British Hypertension Society protocol.|
|Jump to Full Text|
|PMID: 22915946 Owner: NLM Status: PubMed-not-MEDLINE|
|INTRODUCTION: Automatic blood pressure (BP) measuring devices are more and more often used in BP self-checks and in 24-hour BP monitoring. Nowadays, 24-hour BP monitoring is a necessary procedure in arterial hypertension treatment. The aim of this study was to validate the BPLab(®) ambulatory blood pressure monitor according to the European standard BS EN 1060-4:2004 and the British Hypertension Society (BHS) protocol, as well as to work out solutions regarding the suitability of using this device in clinical practice.
METHODS: A group of 85 patients of both sexes and different ages, who voluntarily agreed to take part in the tests and were given detailed instructions on the measurement technique were recruited for this study. The results of the BP measurement obtained by a qualified operator using the BPLab(®) device were compared with the BP values measured using the Korotkov auscultatory method. Data were obtained simultaneously by two experts with experience of over 10 years and had completed a noninvasive BP measurement standardization training course. Discrepancies in the systolic and diastolic BP measurements (N = 510; 255 for each expert) were analyzed according to the criteria specified in the BHS-93 protocol.
RESULTS: The device passed the requirements of the European Standard BS EN 1060-4:2004 and was graded 'A' according to the criteria of the BHS protocol for both systolic BP and diastolic BP.
CONCLUSION: The BPLab(®) 24-hour ambulatory blood pressure monitoring device may be recommended for extensive clinical use.
|Sergey A Koudryavtcev; Vyacheslav M Lazarev|
Related Documents :
|10653426 - Migraine and tension headache in high-pressure and normal-pressure glaucoma.
19936776 - Intraocular pressure changes following descemet's stripping with endothelial keratoplasty.
22915946 - Validation of the bplab(®) 24-hour blood pressure monitoring system according to the e...
2876846 - Ocular effects of a relatively selective alpha 2 agonist (uk-14, 304-18) in cats, rabbi...
11991336 - A model of psychosocial and cultural antecedents of blood pressure control.
7425556 - Blood pressure in relation to age and sex in a semi-urban population.
|Type: Journal Article Date: 2011-10-26|
|Title: Medical devices (Auckland, N.Z.) Volume: 4 ISSN: 1179-1470 ISO Abbreviation: Med Devices (Auckl) Publication Date: 2011|
|Created Date: 2012-08-23 Completed Date: 2012-10-02 Revised Date: 2013-05-30|
Medline Journal Info:
|Nlm Unique ID: 101566041 Medline TA: Med Devices (Auckl) Country: New Zealand|
|Languages: eng Pagination: 193-6 Citation Subset: -|
|Department of Military Medicine, Municipal Medical and Preventive Treatment Facility, 'Clinical Hospital No 12', Sormovsky District, Nizhny Novgorod, Russian Federation.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Med Devices (Auckl)
Journal ID (iso-abbrev): Med Devices (Auckl)
Journal ID (publisher-id): Medical Devices: Evidence and Research
Publisher: Dove Medical Press
© 2011 Koudryavtcev and Lazarev, publisher and licensee Dove Medical Press Ltd.
collection publication date: Year: 2011
Electronic publication date: Day: 26 Month: 10 Year: 2011
Volume: 4First Page: 193 Last Page: 196
PubMed Id: 22915946
Publisher Id: mder-4-193
|Validation of the BPLab® 24-hour blood pressure monitoring system according to the European standard BS EN 1060-4:2004 and British Hypertension Society protocol|
|Sergey A Koudryavtcev|
|Vyacheslav M Lazarev|
|Department of Military Medicine, Municipal Medical and Preventive Treatment Facility, ‘Clinical Hospital No 12’, Sormovsky District, Nizhny Novgorod, Russian Federation
|Correspondence: Correspondence: SA Koudryavtcev, Pavla Mochalova St, 8; Nizhny Novgorod 603003, Russian Federation, Tel +7 8312730309, Mob +7 9047816173, Fax +7 8312730309, Email email@example.com
Automatic blood pressure (BP) measuring devices are more and more often used for BP self-checks and in 24-hour BP monitoring. According to the experts of European Society of Hypertension, 24-hour BP monitoring has been used for research purposes and at present it is mandatorily used in clinical and pharmacological studies and in evaluation of the efficiency of new antihypertensive medical products. Nowadays, 24-hour BP monitoring becomes an obligatory procedure in arterial hypertension detection. Considering the abovementioned, it is essential to objectively evaluate the accuracy of measurements performed by 24-hour BP monitoring devices offered in the market.
In 1990, the British Hypertension Society published a protocol, the purpose of which was to standardize the validation of noninvasive BP measuring instruments.1 This protocol was revised in 1993 and has gained international status.2 In 2004, the British Hypertension Society together with European Society of Hypertension (ESH) published an international standard for the validation of noninvasive sphygmomanometers.3 The principles recommended in the documents provided the basis for work aimed at the validation of the 24-hour BP monitoring device, BPLab® (Petr Telegin Ltd, Nizhny Novgorod, Russia). The results of this validation are given below.
Subject selection was based on the requirements of the Standard EN 1060-4:2004.3 A group of 85 patients of both sexes and different ages, who voluntarily agreed to take part in the tests and were given detailed instructions on the measurement technique, were recruited to participate in this study. All participants provided verbal informed consent of study participation.
Exclusion criteria include: heart failure; significant rhythm disturbances or presence of an artificial pacemaker; pregnancy; and body mass index (BMI) >30 kg/m2.
In accordance with the requirements of the BHS-93 protocol, the results of the BP measurement obtained by a qualified operator using the BPLab device were compared with the BP values measured using the Korotkov auscultatory method simultaneously by two expert medical specialists with over 10 years of experience, who had completed a noninvasive BP measurement standardization training course. The measurements were taken in the morning in comfortable settings (ambient temperature 22°C–25°C, no stimulatory sights or sounds, etc), after the patients had been relaxing in a seated position for 10 minutes. The patients were prohibited to take alcohol <24 hours beforehand or to smoke or take stimulants (tea, coffee, etc) <8 hours before the measurement; they were only allowed to have a light breakfast not less than half an hour before the test. Additionally, taking medication that has a strong effect on the cardiovascular system was not allowed on the day of the measurements.
Expert BP measurements were performed by two experts simultaneously with usage of a high-quality auscultoscope with one head and two headbands, and two individual calibrated sphygmomanometers. The collar dimension depended on the patient’s shoulder girth.
The BP of each patient was measured nine times – alternating between the experts and the tested device – according to the following schedule:
- Measurement A: expert
- Measurement B: instrument
- Measurement 1: expert
- Measurement 2: instrument
- Measurement 3: expert
- Measurement 4: instrument
- Measurement 5: expert
- Measurement 6: instrument
- Measurement 7: expert
The BP was measured on the nondominant arm. The interval between measurements was 30–60 seconds. The BP values obtained by the experts were recorded by each of them according to their own protocol. Three measurement error values were calculated for each patient (for systolic BP [SBP] and diastolic BP [DBP], separately) according to the following formulae:
where BPn is a BP measurement result corresponding to the measurement number n. Measurement A was used to refer a patient to this or that group according to their BP level; measurement B was treated as a calibration measurement.
Discrepancies in the systolic and diastolic BP measurements (N = 510; 255 for each expert) were subsequently analyzed according to the criteria specified in the BHS-93 protocol.
Detailed results of the data analysis are given in Table 3 in the form recommended by the BHS-93 protocol.2 The number of measurement error values which are within the ranges envisaged by the protocol is indicated in the form of a percentage ratio in relation to the total number of measurements.
Figure 1 is a graphical illustration of discrepancies of each measurement depending on the relevant BP value (separately for SBP and DBP). As recommended in the BHS-93 protocol, the figures show only the results of comparison with the expert who obtained closer results (for SBP – observer 2, for DBP – observer 1).
Recently, the accuracy of conventional sphygmomanometers for the measurement of BP has been called into question, and much effort has been made to improve the quality of automatic device measurements.5 Ambulatory BP monitoring is being increasingly recommended for routine clinical practice because it provides valued prognostic data.6,7 The accuracy of BP measuring devices is of great importance and should be validated before devices are put into operation. The aim of this study was to validate the accuracy of the BPLab® 24-hour ambulatory BP monitoring device (Petr Telegin Ltd, Nizhny Novgorod, Russia).
The results of this study suggest that the BPLab® 24-hour ambulatory BP monitoring device passes the test carried out in a mixed group of patients in accordance with the requirements of the European Standard BS EN 1060-4:2004 and the BHS-93 protocol, and may be categorized in the ‘A’ accuracy class according to the abovementioned protocol. The tested device may be recommended for extensive clinical use.
The authors report no conflicts of interest in this work.
|1.||O’Brien E,Petrie J,Littler WA,et al. The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systemsJ HypertensYear: 1990876076192168451|
|2.||O’Brien E,Petrie J,Little WA,et al. The British Hypertension Society protocol for the evaluation of blood pressure measuring devicesJ HypertensYear: 199311Suppl 2S4362|
The European Standard EN 1060-1064:2004. Part 4: Test procedures to determine the overall system accuracy of automated non-invasive sphygmomanometers.
|4.||O’Brien E. Replacing the mercury sphygmomanometer Requires clinicians to demand better automated devicesBMJYear: 2000320723881581610731152|
|5.||O’Brien E,Mee F,Tan KS,Atkins N,O’Malley K. Training and assessment of observers for blood pressure measurement in hypertension researchJ Hum HypertensYear: 1991517102041039|
|6.||Gosse P,Coulon P. Ambulatory or home measurement of blood pressure?J Clin Hypertens (Greenwich)Year: 200911423423719614808|
|7.||Pickering TG,Miller NH,Ogedegbe G,Krakoff LR,Artinian NT,Goff D. American Heart Association; American Society of Hypertension; Preventive Cardiovascular Nurses AssociationCall to action on use and reimbursement for home blood pressure monitoring: Executive summary: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses AssociationHypertensionYear: 2008234299323|
Keywords: 24-hour blood pressure monitoring, device, validation, BPLab®.
Previous Document: Effects of a transmitted light device for pediatric peripheral venipuncture and intravenous cannulat...
Next Document: Development of a colonoscopy add-on device for improvement of the intubation process.